Long-term, open-label experience with an endothelin receptor antagonist, Bosentan, in patients with severe chronic heart failure

Henry Krum, V Charlon, T Widdman, M Packer

Research output: Contribution to conferenceAbstractOther

Original languageEnglish
Pages1-646 - 1-646
Number of pages1
Publication statusPublished - 1999
EventAmerican Heart Association 72nd Scientific Sessions - Atlanta USA, Atlanta, United States of America
Duration: 1 Jan 1999 → …
Conference number: 72

Conference

ConferenceAmerican Heart Association 72nd Scientific Sessions
CountryUnited States of America
CityAtlanta
Period1/01/99 → …

Cite this

Krum, H., Charlon, V., Widdman, T., & Packer, M. (1999). Long-term, open-label experience with an endothelin receptor antagonist, Bosentan, in patients with severe chronic heart failure. 1-646 - 1-646. Abstract from American Heart Association 72nd Scientific Sessions, Atlanta, United States of America.
Krum, Henry ; Charlon, V ; Widdman, T ; Packer, M. / Long-term, open-label experience with an endothelin receptor antagonist, Bosentan, in patients with severe chronic heart failure. Abstract from American Heart Association 72nd Scientific Sessions, Atlanta, United States of America.1 p.
@conference{a5e1e70a51fa429bbbdd3289bcc24a31,
title = "Long-term, open-label experience with an endothelin receptor antagonist, Bosentan, in patients with severe chronic heart failure",
author = "Henry Krum and V Charlon and T Widdman and M Packer",
year = "1999",
language = "English",
pages = "1--646 -- 1--646",
note = "American Heart Association 72nd Scientific Sessions ; Conference date: 01-01-1999",

}

Krum, H, Charlon, V, Widdman, T & Packer, M 1999, 'Long-term, open-label experience with an endothelin receptor antagonist, Bosentan, in patients with severe chronic heart failure' American Heart Association 72nd Scientific Sessions, Atlanta, United States of America, 1/01/99, pp. 1-646 - 1-646.

Long-term, open-label experience with an endothelin receptor antagonist, Bosentan, in patients with severe chronic heart failure. / Krum, Henry; Charlon, V; Widdman, T; Packer, M.

1999. 1-646 - 1-646 Abstract from American Heart Association 72nd Scientific Sessions, Atlanta, United States of America.

Research output: Contribution to conferenceAbstractOther

TY - CONF

T1 - Long-term, open-label experience with an endothelin receptor antagonist, Bosentan, in patients with severe chronic heart failure

AU - Krum, Henry

AU - Charlon, V

AU - Widdman, T

AU - Packer, M

PY - 1999

Y1 - 1999

M3 - Abstract

SP - 1-646 - 1-646

ER -

Krum H, Charlon V, Widdman T, Packer M. Long-term, open-label experience with an endothelin receptor antagonist, Bosentan, in patients with severe chronic heart failure. 1999. Abstract from American Heart Association 72nd Scientific Sessions, Atlanta, United States of America.